Preoperative Cardiac Risk Assessment: Approach & Guidelines

Similar documents
8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Preoperative Risk. Geoffrey C Zarrella DO FACC. Assessment

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

Perioperative Cardiac Management. Emma Sargsyan, MD, FACP

Perioperative Cardiovascular Evaluation and Care for Noncardiac. Dr Mahmoud Ebrahimi Interventional cardiologist 91/9/30

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Evaluation and Management of the Patient with Cardiac Disease for Non-Cardiac Surgery WINTER CONFRENCE 2016 RONY GORGES, MD

Timing of Surgery After Percutaneous Coronary Intervention

COMPARISON OF 2014 ACCAHA VS. ESC GUIDELINES EDITORIAL

Preoperative Evaluation Guidelines and Work up

Clinical Controversies in Perioperative Medicine

Pre-op Risk Assessment. Hal Blanks MD FACC

Preoperative Evaluation of Patients Undergoing Noncardiac Surgery

PERIOPERATIVE CARDIAC RISK ASSESSMENT. Divya Gollapudi, MD

Conflicts of Interest. Evaluation of Cardiac and Pulmonary Risk in the Preop Patient. Introduction. Risk Assessment. Risk Assessment: RCRI

Perioperative Medicine 2016 Some Answers, Even More Questions

Non ST Elevation-ACS. Michael W. Cammarata, MD

Cardiac Risk Assessment in the Preoperative period

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

Preoperative Cardiac Evaluation:

4/27/2015. Cardiac Events #1 cause of postoperative complications/ mortality- CHF, complete heart block, MI,

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

2018 David Stultz. The Consultant s Job

Perioperative Assessment in the Older Adult. Sondra Vazirani, MD, MPH

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Guidelines PATHOLOGY: FATAL PERIOPERATIVE MI NON-PMI N = 25 PMI N = 42. Prominent Dutch Cardiovascular Researcher Fired for Scientific Misconduct

Update in Perioperative Medicine

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Objectives. Old School. Preoperative Evaluation and Postoperative Complications: Where are the opportunities for risk reduction?

D M Y Y Y Y D D M M Y Y Y Y. Previous MI (apart from acute PCI) 0=no 1=yes 9=unknown

Preoperative Evaluation of CABG Patient Needing Non- Cardiac Surgery. Scott Davis, M.D., F.A.C.C. BHHI Primary Care Symposium February 26, 2016

Pre-operative Evaluations. Objectives. General Considerations. FP Consultation Considerations. CV Credits 7/24/2017. Brian Bachelder, MD Akron, Ohio

Clinical Controversies in Perioperative Medicine

Coronary Artery Disease: Revascularization (Teacher s Guide)

Pre-Operative Services Teaching Rounds 3 Jan 2011

Agenda. Perioperative Cardiac Risk Stratification circa Surgical Mortality: What is High Risk? Presenter Disclosure Information

Perioperative Medical Therapy: Beta Blockers, Statins, ACE-Inhibitors, ARB Effects on Mortality

John B. Hill D.O. Department of Anesthesiology NORMAN ANESTHESIA PROVIDERS 03/05/2013

Cardiac Risk Factors and Noninvasive Cardiac Diagnosis-ECG, ECHO, et al. Martin C. Burke, DO, FACOI ACOI IM Board Review Course 2018

Interventions in the Elderly

Controversies in Cardiac Pharmacology

2/17/2010. Grace Lin, MD Assistant Professor of Medicine University of California, San Francisco

Acute Coronary Syndrome. Sonny Achtchi, DO

DUKECATHR Dataset Dictionary

Cardiac Perioperative Risk Assessment American Heart Association Guidelines

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

APPENDIX F: CASE REPORT FORM

SESSION 5 2:20 3:35 pm

PERIOPERATIVE EVALUATION. Brenda Shinar, MD

6/1/18 LEARNING OBJECTIVES PATIENT POPULATION PRESENTATIONS

Update on Perioperative Medicine. Update on Perioperative Medicine. Question 1: Clinical Risk Prediction. for the Office-based Practitioner

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Chest Pain: To Cath or Not? Part I

A few years ago my team was consulted to clear a patient for surgery. I said OK, let s get a pre-op consult note on the chart.

Women and Vascular Disease


Anesthesia for Cardiac Patients for Non Cardiac Surgery. Kimberly Westra DNP, MSN, CRNA

Dr Kerry Gunn. Dr Nicola Broadbent. Anaesthesiologist Auckland City Hospital Auckland. Specialist Anaesthetist Auckland City Hospital Auckland

AMERICAN SOCIETY OF ANESTHESIOLOGISTS ANESTHESIA PRE OPERATIVE SCREENING ASA PHYSICAL STATUS CLASSIFICATION ANESTHESIOLOGISTS

Evaluating the Heart before Non-Cardiac Surgery

Stable Angina: Indication for revascularization and best medical therapy

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

Perioperative Medicine 2017 November 3, Disclosures

Acute Myocardial Infarction

Clinical Controversies in Perioperative Medicine

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

Coronary interventions

I have no disclosures

AAA CAG CAG. ACC / AHA Guidelines for Perioperative Cardiovascular Evaluation for Noncardiac. Group Group AAA AAA.

When Should I Order a Stress Test or an Echocardiogram

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Dual Antiplatelet Therapy Made Practical

10/22/16. Lay of the land. Definition of ACS. Why do we worry about ST elevations?

An update on the management of UA / NSTEMI. Michael H. Crawford, MD

Lessons learned From The National PCI Registry

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

PERIOPERATIVE EVALUATION AND ANESTHETIC MANAGEMENT OF PATIENTS WITH CARDIAC DISEASE FOR NON CARDIAC SURGERY

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018

2/26/2013. Appropriateness Use Criteria (Drilldown) Disclosures. Tony Hermann has nothing to disclose. Mark Hutcheson has nothing to disclose

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

Use of Nuclear Cardiology in Myocardial Viability Assessment and Introduction to PET and PET/CT for Advanced Users

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease

Detailed Order Request Checklists for Cardiology

Controversies in Perioperative Medicine

2010 ACLS Guidelines. Primary goals of therapy for patients

Agenda. Disclosures. Surgical Mortality: What is High Risk?

Data Elements and Definitions with Case Studies. Interpreting Your Outcomes Reports. Kim Hustler, Clinical Quality Consultant, NCDR

Difficult Data Definitions and Scenario s

PRE Operative Care of the High Risk Surgical Patient. Dr A T Dewhurst Consultant Anaesthetist St George s Hospital London

An algorithmic approach to the very high risk surgical patient

ESC GUIDELINES ON DIABETES AND CARDIOVASCULAR DISEASES

Transcription:

Preoperative Cardiac Risk Assessment: Approach & Guidelines By, Liam Morris, MD., FACC (02/03/18)

CPG : Clinical Practice Guidelines GDMT : Guidelines Directed Medical Therapy GWC : Guideline Writing Committee ERC : Evidence Review Committee RCT : Randomized Clinical Trials MACE : Major Adverse Cardiac Events (Death and Nonfatal MI) ACS : Acute Coronary Syndrome

Definitions Emergency procedure : One in which Life or a Limb is threatened, < 6 hours Urgent Procedure : One in which Life or a Limb is threatened, typically between 6 and 24 hours Time sensitive procedure : 1 6 weeks (Oncologic procedures) Elective procedure : The procedure could be delayed up to 1 year

Low Risk procedure : Combined surgical and patient characteristics predict a MACE or MI of less than 1% (Plastic Surgery, Cataract Surgery) Elevated Risk procedure : Risk of MACE of greater than or equal to 1%

Functional Capacity METs : Metabolic Equivalents, where 1 MET is the resting or basal Oxygen consumption of a 40 year old, 70 kg man Classification: Excellent : > 10 METs Good : 7 10 METs Moderate : 4 6 METs Poor : < 4 METs (Slow Ballroom Dancing, Golfing & Walking at 2 3 mph)

Key Point Walking up a flight of Stairs Heavy house work Walking at 4 mph > 4 METs

Stepwise Approach Step 1 Determine the Urgency of Surgery - if EMERGENT; Determine the clinical risk factors that may influence perioperative management, and proceed to Surgery with appropriate monitoring and management strategies based on clinical assessment

Step 2 If Urgent or Elective; Determine if the patient has an ACS

STEMI UA/NSTEMI Decompensated Heart Failure (Peri partum Cardiomyopathy) Significant Arrhythmias Severe Valvular Heart Disease (2 D ECHO preoperatively in Moderate to severe Valvular Heart Disease if not performed in the last year, or if there is a change in clinical status)

When your back is against the wall Reasonable to proceed to Surgery if; a) Asymptomatic + Severe AS (Class II A) b) Asymptomatic + Severe MS (Class II B) c) Asymptomatic + Severe AI (Class II A) d) Asymptomatic + Severe MR (Class II A) (Swan - Ganz Catheter Placement, TEE)

Pulmonary Vascular Disease Increased perioperative risk; a) WHO Group 1 Pulmonary HTN b) Pulmonary Artery Systolic Pressures of > 70 mmhg c) Moderate (or greater) RV Dilatation/Dysfunction d) Pulmonar Vascular Resistance > 3 Wood Units e) NYHA Class III or IV Heart Failure (due to Pulmonary HTN) (Pulmonary HTN Specialist, Right Heart Catheterization)

Step 3 Estimate the Risk; NSQIP Risk Calculator RCRI Score a) Low Risk for MACE (0 0r 1 risk factor) b) Elevated Risk for MACE (greater than or equal to 2 risk factors) 1) High Risk Type of Surgery (Vascular surgery, Intraperitoneal and Intrathoracic surgeries) 2) H/O Ischemic Heart Disease (H/O MI, Pathological Q Waves on EKG, + Stress Test, Nitrate Therapy or Angina) 3) History of Heart Failure 4) H/O Cerebrovascular Disease 5) Diabetes Mellitus requiring treatment with Insulin 6) Preoperative Serum Creatinine of > 2 mg/dl

Step 4 If the patient has Low Risk (o or 1 Risk factor) of MACE (< 1%), proceed with Surgery

Step 5 If the patient has elevated risk of MACE (greater than or equal to 1%), then determine the Functional Capacity. If greater than or equal to 4 METs, proceed with Surgery.

Step 6 If Functional Capacity is poor (< 4 METs), then consult with the patient to determine if further testing would impact patient decision making. If Yes, then perform a Pharmacological Cardiac Stress Test (especially if Functional Capacity cannot be determined) If normal, proceed to Surgery with GDMT If abnormal, consider Coronary Angiography & Revascularization based on the extent of the abnormal Stress Test

Step 7 If testing does not impact decision making or care, to proceed to Surgery with GDMT or explore non invasive therapies

Preoperative EKG Class IIA : Reasonable for H/O Heart Disease, PAD, CVA (LOE: B) Class III : Routine testing is not useful for asymptomatic patients undergoing Low Risk Surgery (LOE: B)

Preoperative ECHO Class II A : a) Dyspnea of unknown origin (LOE: C) b) Heart Failure patients with worsening Dyspnea or change in clinical status (LOE: C) Class III : Routine Echocardiography is not recommended

Preoperative Stress Testing DSE (Dobutamine Stress ECHO) or MPI (Myocardial Perfusion Imaging) a) Moderate to large areas of Myocardial Ischemia is associated with increased risk of perioperative MI and/or Death b) A normal study has a very high negative predictive value c) The presence of an old MI is of little predictive value for perioperative MI or cardiac death

Preoperative Coronary Revascularization Class I : Revascularization is recommended in circumstances in which it is indicated according to CPGs (LOE: C) a) If Evaluation recommends Surgical revascularization (CABG) Go for it! b) Percutaneous Revascularization should be considered for 1) Left Main Disease in poor surgical candidates 2) Unstable CAD 3) NSTEMI/STEMI consider POBA/BMS Class III : Routine Revascularization before non cardiac surgery is not recommended (LOE: B)

Timing of Elective Surgery (post PCI) Class I : a) POBA : 2 weeks (LOE: C) b) BMS : 4 weeks (LOE: B) c) DES : 1 year (LOE: B) Class IIB : Elective Surgery after DES may be considered after 180 days if the risk of further delay is greater than the expected risks of Ischemia and Stent Thrombosis (LOE: B)

Perioperative Beta Blocker (BB) Therapy Class I : BBs should be continued perioperatively for those who have been on it chronically (LOE: B) Class II B : BB can be initiated in the following settings; 1) Intermediate or High Risk Myocardial Ischemia prior to the procedure (LOE: C) 2) 3 or more RCRI risk factors (LOE: B)

Timing of Initiation: 2 7 days before the procedure Class III : BB therapy SHOULD NOT BE STARTED ON THE DAY OF SURGERY

Perioperative Statin Therapy Class I : Statins should be continued perioperatively for those who have been on it chronically (LOE: B) Class IIA : Statins can be considered in those undergoing Vascular Surgery (LOE: B)

Perioperative Aspirin (ASA) Therapy Class III : Initiation or continuation of ASA is not beneficial in patients undergoing non cardiac or non carotid surgery, who have not had previous stenting, unless the risk of Ischemic events outweigh the risks of surgical bleeding (LOE: C)

Sample Notes The patient is at Low perioperative risk for major adverse cardiac events (< 1% risk for Death and non fatal MI). No further cardiac testing is indicated at this time. To proceed to Surgery, continue BB and Statin therapy perioperatively. The patient is at Elevated perioperative risk for major adverse cardiac events (greater than or equal to 1% risk for Death and non fatal MI). However, further cardiac testing is unlikely to impact decision making or care, and is therefore not indicated at this time. To proceed to Surgery, continue BB and Statin therapy perioperatively. The patient is at Elevated perioperative risk for major adverse cardiac events (greater than or equal to 1% risk for Death and non fatal MI). To order a Cardiac Stress Test prior to the procedure for further risk stratification.

Question 1 81 Y/O AAM with a H/O CAD S/P CABG (1985), PAD S/P PTA to the Right SFA (2013), DM, HTN, Hyperlipidemia, CKD Stage 4 and CVA (2008) with no residual neurological deficits is about to undergo Cataract Surgery. His Ophthalmologist calls you for Preoperative Evaluation. Low Risk for MACE. Proceed with Surgery

Question 2 56 Y/O WM with a H/O CAD S/P PCI to the LAD (2014), DM, HTN and Hyperlipidemia is about to undergo Right Inguinal Herniorrhaphy. He however, gives a history of worsening chest pain (similar to the pain he experienced prior to his Stent Placement) over the last 2 weeks. Physical Exam reveals a Right Inguinal Hernia without signs of Incarceration. His Surgeon wants to know if he could proceed with the procedure. Unstable Angina the heart comes first!

Question 3 45 Y/O AAF with a H/O DM and HTN who was admitted for elective Hiatal Hernia repair. She develops chest pain soon after admission, and an EKG revealed Lateral ST depressions concerning for Ischemia. Cardiac Enzymes showed an elevated troponin of 2 ng/ml. She wants to go ahead with the planned procedure, and the surgeon seeks your help. NSTEMI Left heart catheterization and possible PCI!!!!

Question 4 65 Y/O WM with a H/O DM (on Metformin), HTN and Hyperlipidemia who was referred to the Cardiology Clinic for Preoperative Evaluation prior to Lumbar Laminectomy. Low Risk for MACE. Proceed with Surgery

Question 5 31 Y/O WM with no significant PMH comes to the ED with C/O intense RLQ Abdominal Pain. He was subsequently diagnosed with Acute Appendicitis. The first year surgical resident calls you for preoperative evaluation. Be Nice!!!!! Proceed to surgery.

Question 6 Dr Gill from the VA Medical Center calls you about a 65 Y/O AAM with a H/O CAD S/P PCI to the LAD (2010), Ischemic Cardiomyopathy (EF of 35% per 2 D ECHO), DM, CKD Stage 3 (Creatinine of 2.1 mg/dl), HTN and Hyperlipidemia who presented for an elective Right Carotid Endarterectomy, and was not cleared by Cardiology. He is asymptomatic from a cardiac standpoint, and can climb a flight of stairs without discomfort. He is currently on ASA, Metoprolol, Lisinopril, Simvastatin and Insulin. Proceed to surgery. Continue ASA, BB and Statin therapy

Question 7 Part 1 75 Y/O WM with a H/O CAD S/P PCI to the LAD (2009), CVA (2010) with residual left sided weakness, DM (requiring Insulin), HTN and Hyperlipidemia who is about to undergo a Left Great Toe Amputation for a chronic non healing ulcer. His functional capacity is extremely limited due to his Stroke. The vascular surgeon would like you to evaluate his cardiac risk prior to the procedure. Cardiac Stress Test

Part 2 The patient however refuses to undergo Bypass Surgery or PCI should the Cardiac Stress Test reveal abnormalities. He just wants this darn toe off. Proceed to Surgery with GDMT

Part 3 He speaks to his wife the next day, and suddenly has a change of heart. He is willing to undergo Coronary Angiography and further therapy for the same should it be indicated. The Cardiac Stress Test reveals a large reversible perfusion defect in the anterior wall and the apex. He subsequently undergoes Coronary Angiography, which reveals critical Left Main Disease. Consult Cardiothoracic Surgery!

Thank You!!!